New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMThis group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS
All plain beta blocking agents are classified in this group.
Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.
Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.
| The DDDs are based on the treatment of mild-moderate hypertension. The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol. |
C07AA Beta blocking agents, non-selective
All plain non-selective beta blocking agents are classified in this group.
C07AB Beta blocking agents, selective
All plain selective beta blocking agents are classified in this group.
The s-enantiomer and the racemate of atenolol are classified at separate 5th levels.
| Different DDDs have been assigned for the two stereoisomeric forms of atenolol due to different potency. |
C07AG Alpha and beta blocking agents
Last updated: 2024-01-26